Han Chung Kelvin Chong

Title: Han Chung Kelvin Chong: Innovator in Wound Healing and Diagnostic Biomarkers

Introduction

Han Chung Kelvin Chong is a prominent inventor based in Singapore, SG. He has made significant contributions to the fields of wound healing and diagnostic biomarkers, holding a total of 3 patents. His innovative work has the potential to impact medical treatments and improve patient outcomes.

Latest Patents

Chong's latest patents include groundbreaking inventions such as "Angiopoietin-like 4 and a method of its use in wound healing." This patent describes a method and a pharmaceutical composition for increasing wound healing in individuals, which involves administering an angiopoietin-like 4 (ANGPTL4) polypeptide or a therapeutically active fragment thereof. Another notable patent is "Angiopoietin-related protein 4 (cAngptl4) as a diagnostic biomarker for acute lung damage." This invention relates to the C-terminal fragment of angiopoietin-related protein 4 as a diagnostic marker for viral and bacterial pneumonia, along with the development of anti-angiopoietin-related protein 4 therapeutic antibodies for treatment.

Career Highlights

Chong has worked with esteemed institutions such as Nanyang Technological University and the National University of Singapore. His experience in these organizations has allowed him to collaborate with leading researchers and contribute to significant advancements in his field.

Collaborations

Some of his notable coworkers include Nguan Soon Tan and Vincent Tak Kwong Chow. Their collaborative efforts have further enhanced the impact of Chong's research and innovations.

Conclusion

Han Chung Kelvin Chong is a distinguished inventor whose work in wound healing and diagnostic biomarkers showcases his commitment to advancing medical science. His patents reflect a dedication to improving healthcare outcomes and highlight the importance of innovation in the medical field.